⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15459384 | 0.75 | — | — | |
| SCHEMBL21077263 | 0.67 | — | — | |
| SCHEMBL18551874 | 0.64 | — | — | |
| SCHEMBL58951 | 0.64 | MEN1 (0.38) | — | |
| SCHEMBL3220202 | 0.64 | — | — | |
| SCHEMBL21077274 | 0.64 | — | — | |
| SCHEMBL25256307 | 0.64 | MEN1 (0.38) | — | |
| SCHEMBL14273790 | 0.64 | — | — | |
| SCHEMBL6932727 | 0.64 | MEN1 (0.38) | — | |
| SCHEMBL14340974 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090226491-A1 | Water-based delivery systems | SKOLD, THOMAS (SE) | 2009-09-10 | — | — | US | claimed |
| WO-2006039667-A2 | WATER-BASED DELIVERY SYSTEMS | COLLAGENEX PHARMACEUTICALS, INC. (US) | 2006-04-13 | — | — | WO | claimed |
| US-20050129722-A1 | For an active substance, characterized by enhancing skin barrier restoration in the stratum corneum comprising a fatty acid, cholesterol, a ceramide and at least one skin lipid precursor; topical drug delivery | COLLAGENEX PHARMACEUTICALS, INC. | 2005-06-16 | — | — | US | claimed |
| CN-1303403-A | Sulphur products for adding polythiol on norbornene derivative, preparation method and use for obtaining radical cross-linking products | CRAY VALLEY SA (FR) | 2001-07-11 | — | — | CN | claimed |
| EP-0714402-A1 | POLYMER MODIFICATION | PolyMASC Pharmaceuticals plc (GB) | 1996-06-05 | — | — | EP | claimed |
| WO-1995006058-A1 | POLYMER MODIFICATION | POLYMASC PHARMACEUTICALS PLC (GB) | 1995-03-02 | — | — | WO | claimed |
| EP-4397771-A2 | URINE STABILIZATION | PreAnalytiX GmbH (CH) | 2024-07-10 | — | — | EP | disclosed |
| US-20230311068-A1 | METHOD FOR PREPARING POROUS POLYMER SEMIPERMEABLE MEMBRANE AND PRODUCT THEREOF | DREISAM (BEIJING) MEDICAL TECHNOLOGY CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| EP-4218411-A2 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | QIAGEN GmbH (DE) | 2023-08-02 | — | — | EP | disclosed |
| US-11639342-B2 | 1,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry | Bioconjugate Technologies, LLC (US) | 2023-05-02 | — | — | US | disclosed |
| EP-1991273-B2 | LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS | LIFE TECHNOLOGIES CORP (US) | 2022-01-05 | — | — | EP | disclosed |
| EP-3905881-A1 | URINE STABILIZATION | QIAGEN GmbH (DE) | 2021-11-10 | — | — | EP | disclosed |
| CN-113286512-A | Urine stabilization | 凯杰有限公司 | 2021-08-20 | — | — | CN | disclosed |
| CN-1173490-A | Thiol and sulfur-containing 0- (meth) acrylate compound and use thereof | MITSUI TOATSU CHEMICALS (JP) | 1998-02-18 | — | — | CN | disclosed |
| CN-1138611-A | Waterborne zinc-rich primer compositions | ROHM & HAAS (US) | 1996-12-25 | — | — | CN | disclosed |
| EP-0714402-A1 | POLYMER MODIFICATION | PolyMASC Pharmaceuticals plc (GB) | 1996-06-05 | — | — | EP | disclosed |
| WO-1995006058-A1 | POLYMER MODIFICATION | POLYMASC PHARMACEUTICALS PLC (GB) | 1995-03-02 | — | — | WO | disclosed |
| EP-0015887-B1 | IMPROVED LAUNDERING METHOD | THE PROCTER & GAMBLE COMPANY (US) | 1985-05-08 | — | — | EP | disclosed |
| US-4332692-A | REMOVAL OF OILY SOILS FROM FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 1982-06-01 | — | — | US | disclosed |
| EP-0015887-A1 | Improved laundering method | THE PROCTER & GAMBLE COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |